Mirus Life Science Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.80 M
- Revenue Growth -17.02%
- Profit Growth 49.66%
- Ebitda -65.94%
- Net Worth -189.23%
- Total Assets -5.90%
About Mirus Life Science
Mirus Life Science Private Limited (MLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 September 2013 and has a history of 11 years and five months. Its registered office is in Ahmed Nagar, Maharashtra, India.
The Company is engaged in the Health And Wellness Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.80 M.
Nikhil Malhotra and Abhilash Malhotra serve as directors at the Company.
Company Details
-
Location
Ahmed Nagar, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U52390PN2013PTC148701
-
Company No.
148701
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Sep 2013
-
Date of AGM
27 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Mirus Life Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nikhil Malhotra
|
Director | 03-Sep-2013 | Current |
|
Abhilash Malhotra
|
Director | 03-Sep-2013 | Current |
Financial Performance of Mirus Life Science.
Mirus Life Science Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 17.02% decrease. The company also saw a substantial improvement in profitability, with a 49.66% increase in profit. The company's net worth observed a substantial decline by a decrease of 189.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mirus Life Science?
In 2018, Mirus Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.80 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jan 2018 | State Bank Of India | ₹0.80 M | Open |
How Many Employees Work at Mirus Life Science?
Unlock and access historical data on people associated with Mirus Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mirus Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mirus Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.